Camille Vellas

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab

J. Izopet, N. Kamar, G. Martin-Blondel, 2022, Clinical Microbiology and Infection.

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment

J. Izopet, N. Kamar, Camille Vellas, 2022, Journal of Infection.

COVID-19, Virology and Geroscience: A Perspective

J. Izopet, P. de Souto Barreto, P. Delobel, 2020, The journal of nutrition, health & aging.

Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients

J. Izopet, N. Kamar, S. Faguer, 2021, Transplantation.

Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study

J. Izopet, S. Raymond, F. Abravanel, 2021, Diagnostic Microbiology and Infectious Disease.

Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies

J. Izopet, N. Kamar, G. Martin-Blondel, 2021, Clinical Microbiology and Infection.

Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies

J. Izopet, N. Kamar, G. Martin-Blondel, 2022, Open forum infectious diseases.

Intact proviruses are enriched in the colon and associated with PD-1+TIGIT− mucosal CD4+ T cells of people with HIV-1 on antiretroviral therapy

G. Martin-Blondel, C. Dimeglio, N. Jeanne, 2023, EBioMedicine.